Brief: Cereno Signs CRO To Conduct Phase I Study Of Drug Candidate CS014

Cereno Scientific AB

20/09/2023 08:58

Sept 20 (Reuters) - Cereno Scientific AB  CRNOSb.ST :
    * CERENO SCIENTIFIC SIGNS CRO TO CONDUCT PHASE I STUDY OF
DRUG
CANDIDATE CS014
    * FIRST-IN-HUMAN PHASE I STUDY IS PLANNED TO BE INITIATED
DURING
FIRST HALF OF 2024

Source text for Eikon:  ID:nWkrbhFD8b 
Further company coverage:  CRNOSb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))